» Articles » PMID: 34866179

Both Full Length-cholesteryl Ester Transfer Protein and Exon 9-deleted Cholesteryl Ester Transfer Protein Promote Triacylglycerol Storage in Cultured Hepatocytes

Overview
Journal Lipids
Specialty Biochemistry
Date 2021 Dec 6
PMID 34866179
Authors
Affiliations
Soon will be listed here.
Abstract

We previously reported that overexpression of full-length cholesteryl ester transfer protein (FL-CETP), but not its exon 9-deleted variant (∆E9-CETP), in an adipose cell line reduces their triacylglycerol (TAG) content. This provided mechanistic insight into several in vivo studies where FL-CETP levels are inversely correlated with adiposity. However, increased FL-CETP is also associated with elevated hepatic lipids, suggesting that the effect of CETP on cellular lipid metabolism may be tissue-specific. Here, we directly investigated the role of FL-CETP and ∆E9-CETP in hepatic lipid metabolism. FL- or ∆E9-CETP was overexpressed in HepG2-C3A by adenovirus transduction. Overexpression of either FL or ∆E9-CETP in hepatocytes increased cellular TAG mass by 25% but reduced TAG secretion. This cellular TAG was contained in larger and more numerous lipid droplets. Analysis of TAG synthetic and catabolic pathways showed that this elevated TAG content was due to increased incorporation of fatty acid into TAG (24%), and higher de novo synthesis of fatty acid (50%) and TAG from acetate (40%). siRNA knockdown of CETP had the opposite effect on TAG synthesis and lipogenesis, and decreased cellular TAG. This novel increase in cellular TAG by FL-CETP overexpression was reproduced in Caco-2 intestinal epithelial cells. We conclude that, unlike that seen in adipocyte cells, overexpression of either CETP isoform in lipoprotein-secreting cells promotes the accumulation of TAG. These data suggest that the in vivo correlation between CETP levels and hepatic steatosis can be explained, in part, by a direct effect of CETP on hepatocyte cellular metabolism.

References
1.
Taghibiglou C, Van Iderstine S, Kulinski A, Rudy D, Adeli K . Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor. Biochem Pharmacol. 2002; 63(3):349-60. DOI: 10.1016/s0006-2952(01)00918-2. View

2.
Blake W, Ulrich R, Marotti K, Melchior G . The development of fatty liver is accelerated in transgenic mice expressing cynomolgus monkey cholesteryl ester transfer protein. Biochem Biophys Res Commun. 1994; 205(2):1257-63. DOI: 10.1006/bbrc.1994.2800. View

3.
Klerkx A, Harchaoui K, van der Steeg W, Boekholdt S, Stroes E, Kastelein J . Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis. Arterioscler Thromb Vasc Biol. 2006; 26(4):706-15. DOI: 10.1161/01.ATV.0000205595.19612.c9. View

4.
Izem L, MORTON R . Cholesteryl ester transfer protein biosynthesis and cellular cholesterol homeostasis are tightly interconnected. J Biol Chem. 2001; 276(28):26534-41. DOI: 10.1074/jbc.M103624200. View

5.
Dessi M, Motti C, Cortese C, Leonardis E, Giovannini C, Federici G . Alternative splicing of human plasma cholesteryl ester transfer protein mRNA in Caco-2 cells and its modulation by oleic acid. Mol Cell Biochem. 1998; 177(1-2):107-12. DOI: 10.1023/a:1006823601032. View